OpenSky Uptake Intelligence for Pharma

OpenSky Uptake Intelligence is a proprietary insight platform and consulting service built on Microsoft Fabric and Azure AI, created specifically for pharmaceutical Market Access, Medical, and Commercial teams. It unifies real-world data, behavioural signals, provider activity, and intervention outcomes into a continuous intelligence cycle — showing where adoption is strong or weak, why it's happening, and what actions are most likely to change behaviour. Unlike generic analytics deployments, Uptake Intelligence comes with OpenSky’s pre-built pharma data model, ML engines, and decision-support frameworks, enabling rapid time-to-value and repeatable adoption insights across therapeutic areas and global markets. Using explainable AI and domain expertise, the platform helps teams quantify drivers/barriers, evaluate intervention effectiveness, and receive next-best action recommendations that strengthen go-to-market performance, reduce inequities, and improve therapy and vaccine uptake.

Key Outcomes By the end of the engagement, you will be able to: • Quantify real-world drivers & barriers of therapy/vaccine uptake across regions, populations, and HCP segments. • Evaluate the impact of interventions (education, field force, HCP activation, digital campaigns, policy activity) through an assistive AI Agent. • Receive AI-generated recommendations for next-best actions, with human interpretation from OpenSky consultants. • The Uptake Intelligence platform comes with an interactive Power BI environment showing uptake patterns, inequalities, segmentation, drivers, and predictions. • Establish a scalable, reproducible intelligence foundation across therapeutic areas and global markets.

About the Engagement The engagement is delivered using OpenSky’s proprietary Uptake Intelligence platform, built on Microsoft Fabric and Azure AI. OpenSky provides a ready-made, pharma-specific intelligence solution with pre-configured models, data structures, insight frameworks, and decision-support assets tailored for therapy and vaccine adoption. Phase 1 – Data Ingestion & Fabric Environment Setup (1–3 weeks)

1. Deployment of the OpenSky Uptake Intelligence data model, built specifically for Market Access, Medical and Commercial use cases.
2. Integration of internal data sources (CRM, claims, registry, sales) and external datasets (public health, demographic, scientific knowledge base).
3. Validation using OpenSky’s predefined pharma ingestion templates and behavioural signal schema, ensuring rapid time-to-value.

Phase 2 – Configure OpenSky’s AI Insight Engine (2–4 weeks)

1. Use of OpenSky’s pre-built uptake ML models (drivers/barriers models, segmentation, equity analysis, HCP influence, forecasting).
2. AI explainability layers designed specifically for therapy adoption and policy engagement.
3. Scenario modelling using OpenSky’s decision-impact framework, enabling early identification of opportunities and next-best actions.

Phase 3 – Power BI Insights & Collaborative Intelligence (1–2 weeks) Deployment of the OpenSky Uptake Intelligence dashboard suite, including: • Uptake variation explorer • Regional & population segmentation • HCP influence analysis • Inequalities detection • Intervention impact evaluation • Scenario modelling & prediction Plus; built-in collaboration features such as annotation, co-authoring, shared workspaces, and versioned insight reviews.

Phase 4 – Interpretation, Adoption, Consulting & Next-Best Actions (2 weeks)

1. AI-generated recommendations validated and refined by OpenSky consultants with deep pharma expertise.
2. Cross-functional workshop translating platform outputs into Market Access, Medical, and Commercial action plans.
3. Expansion roadmap using OpenSky’s scalable multi-market adoption framework, enabling rollout across geographies and therapeutic areas.

Who Is This For? This offer is designed for pharmaceutical organisations with marketed or launching therapies, especially in vaccines, infectious disease, immunology, oncology, and rare disease.

What You Will Get from the Engagement:

1. Uptake Drivers & Barriers Assessment: A clear view of the real-world factors influencing therapy or vaccine adoption across regions, populations, and provider groups.
2. Segmented Uptake Insights: Visibility into where adoption is strong or weak — and why.
3. Intervention Effectiveness Evaluation: Evidence showing which education, access, HCP, digital, or field activities are working — and which are not.
4. Action Recommendations: Targeted, prioritised recommendations for where to focus resources to improve uptake.
5. Regional Opportunity Mapping: Identification of high-opportunity regions or segments for stronger uptake impact.
6. Visual Decision Dashboards: Easy-to-use business dashboards that summarise trends, barriers, and opportunities in one place for cross functional teams.